MCIM
NXTM

Meadow Creek Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Meadow Creek Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,916
Closed -$147K – 1356
2018
Q1 		$147K Sell
5,916
-17,918
-75% -$436K ﹤0.01% 1100
2017
Q4 		$577K Sell
23,834
-17,068
-42% -$450K 0.01% 611
2017
Q3 		$1.13M Sell
40,902
-5,100
-11% -$136K 0.03% 387
2017
Q2 		$1.15M Sell
46,002
-15,334
-25% -$380K 0.03% 382
2017
Q1 		$1.65M Hold
61,336
– – 0.04% 324
2016
Q4 		$1.61M Buy
+61,336
New +$1.52M 0.04% 308

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.38% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.56% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Meadow Creek Investment Management's NXTM Position: Q2 2018 in Review

Meadow Creek Investment Management sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 5,916 shares — an estimated $147K sold.

Meadow Creek Investment Management first reported a position in NXTM in Q4 2016 and held it in 6 quarters. The position peaked at $1.65M in Q1 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • Meadow Creek Investment Management reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • Meadow Creek Investment Management sold 5,916 NxStage Medical Inc. shares in Q2 2018, an estimated $147K.
  • Meadow Creek Investment Management first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 6 quarters.
  • Meadow Creek Investment Management's NxStage Medical Inc. position peaked at $1.65M in Q1 2017.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Meadow Creek Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.